Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction
Condition(s):Colon CancerLast Updated:May 30, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Colon CancerLast Updated:May 30, 2019Completed
Condition(s):Solar UrticariaLast Updated:October 12, 2018Completed
Condition(s):AsthmaLast Updated:July 9, 2018Completed
Condition(s):UrticariaLast Updated:July 15, 2014Unknown status
Condition(s):Chronic Spontaneous UriticariaLast Updated:September 21, 2016Completed
Condition(s):Allergic AsthmaLast Updated:December 22, 2015Completed
Condition(s):Allergic AsthmaLast Updated:December 11, 2017Completed
Condition(s):AsthmaLast Updated:October 3, 2016Unknown status
Condition(s):Immune System DiseasesLast Updated:December 10, 2015Completed
Condition(s):AsthmaLast Updated:December 11, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.